WT1 regulates angiogenesis in Ewing Sarcoma

Varalakshmi Katuri, Stephanie Gerber, Xiaofei Qiu, Gregory McCarty, Seth D. Goldstein, Hans Hammers, Elizabeth Montgomery, Allen R. Chen, David M. Loeb

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Angiogenesis is required for tumor growth. WT1, a protein that affects both mRNA transcription and splicing, has recently been shown to regulate expression of vascular endothelial growth factor (VEGF), one of the major mediators of angiogenesis. In the present study, we tested the hypothesis that WT1 is a key regulator of tumor angiogenesis in Ewing sarcoma. We expressed exogenous WT1 in the WT1-null Ewing sarcoma cell line, SK-ES-1, and we suppressed WT1 expression using shRNA in the WT1-positive Ewing sarcoma cell line, MHH-ES. Suppression of WT1 in MHH-ES cells impairs angiogenesis, while expression of WT1 in SK-ES-1 cells causes increased angiogenesis. Different WT1 isoforms result in vessels with distinct morphologies, and this correlates with preferential upregulation of particular VEGF isoforms. WT1-expressing tumors show increased expression of pro-angiogenic molecules such as VEGF, MMP9, Ang-1, and Tie-2, supporting the hypothesis that WT1 is a global regulator of angiogenesis. We also demonstrate that WT1 regulates the expression of a panel of pro-angiogenic molecules in Ewing sarcoma cell lines. Finally, we found that WT1 expression is correlated with VEGF expression, MMP9 expression, and microvessel density in samples of primary Ewing sarcoma. Thus, our results demonstrate that WT1 expression directly regulates tumor angiogenesis by controlling the expression of a panel of pro-angiogenic genes.

Original languageEnglish (US)
Pages (from-to)2436-2449
Number of pages14
JournalOncotarget
Volume5
Issue number9
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Ewing's Sarcoma
Vascular Endothelial Growth Factor A
Cell Line
Neoplasms
Protein Isoforms
Microvessels
Small Interfering RNA
Up-Regulation
Messenger RNA
Growth
Genes
Proteins

Keywords

  • Alternative splicing
  • Tissue microarray
  • Transcriptional regulation
  • Tumor angiogenesis
  • Vascularity

ASJC Scopus subject areas

  • Oncology

Cite this

Katuri, V., Gerber, S., Qiu, X., McCarty, G., Goldstein, S. D., Hammers, H., ... Loeb, D. M. (2014). WT1 regulates angiogenesis in Ewing Sarcoma. Oncotarget, 5(9), 2436-2449. https://doi.org/10.18632/oncotarget.1610

WT1 regulates angiogenesis in Ewing Sarcoma. / Katuri, Varalakshmi; Gerber, Stephanie; Qiu, Xiaofei; McCarty, Gregory; Goldstein, Seth D.; Hammers, Hans; Montgomery, Elizabeth; Chen, Allen R.; Loeb, David M.

In: Oncotarget, Vol. 5, No. 9, 01.01.2014, p. 2436-2449.

Research output: Contribution to journalArticle

Katuri, V, Gerber, S, Qiu, X, McCarty, G, Goldstein, SD, Hammers, H, Montgomery, E, Chen, AR & Loeb, DM 2014, 'WT1 regulates angiogenesis in Ewing Sarcoma', Oncotarget, vol. 5, no. 9, pp. 2436-2449. https://doi.org/10.18632/oncotarget.1610
Katuri V, Gerber S, Qiu X, McCarty G, Goldstein SD, Hammers H et al. WT1 regulates angiogenesis in Ewing Sarcoma. Oncotarget. 2014 Jan 1;5(9):2436-2449. https://doi.org/10.18632/oncotarget.1610
Katuri, Varalakshmi ; Gerber, Stephanie ; Qiu, Xiaofei ; McCarty, Gregory ; Goldstein, Seth D. ; Hammers, Hans ; Montgomery, Elizabeth ; Chen, Allen R. ; Loeb, David M. / WT1 regulates angiogenesis in Ewing Sarcoma. In: Oncotarget. 2014 ; Vol. 5, No. 9. pp. 2436-2449.
@article{e8648412213f4ab9a30305716b204c67,
title = "WT1 regulates angiogenesis in Ewing Sarcoma",
abstract = "Angiogenesis is required for tumor growth. WT1, a protein that affects both mRNA transcription and splicing, has recently been shown to regulate expression of vascular endothelial growth factor (VEGF), one of the major mediators of angiogenesis. In the present study, we tested the hypothesis that WT1 is a key regulator of tumor angiogenesis in Ewing sarcoma. We expressed exogenous WT1 in the WT1-null Ewing sarcoma cell line, SK-ES-1, and we suppressed WT1 expression using shRNA in the WT1-positive Ewing sarcoma cell line, MHH-ES. Suppression of WT1 in MHH-ES cells impairs angiogenesis, while expression of WT1 in SK-ES-1 cells causes increased angiogenesis. Different WT1 isoforms result in vessels with distinct morphologies, and this correlates with preferential upregulation of particular VEGF isoforms. WT1-expressing tumors show increased expression of pro-angiogenic molecules such as VEGF, MMP9, Ang-1, and Tie-2, supporting the hypothesis that WT1 is a global regulator of angiogenesis. We also demonstrate that WT1 regulates the expression of a panel of pro-angiogenic molecules in Ewing sarcoma cell lines. Finally, we found that WT1 expression is correlated with VEGF expression, MMP9 expression, and microvessel density in samples of primary Ewing sarcoma. Thus, our results demonstrate that WT1 expression directly regulates tumor angiogenesis by controlling the expression of a panel of pro-angiogenic genes.",
keywords = "Alternative splicing, Tissue microarray, Transcriptional regulation, Tumor angiogenesis, Vascularity",
author = "Varalakshmi Katuri and Stephanie Gerber and Xiaofei Qiu and Gregory McCarty and Goldstein, {Seth D.} and Hans Hammers and Elizabeth Montgomery and Chen, {Allen R.} and Loeb, {David M.}",
year = "2014",
month = "1",
day = "1",
doi = "10.18632/oncotarget.1610",
language = "English (US)",
volume = "5",
pages = "2436--2449",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "9",

}

TY - JOUR

T1 - WT1 regulates angiogenesis in Ewing Sarcoma

AU - Katuri, Varalakshmi

AU - Gerber, Stephanie

AU - Qiu, Xiaofei

AU - McCarty, Gregory

AU - Goldstein, Seth D.

AU - Hammers, Hans

AU - Montgomery, Elizabeth

AU - Chen, Allen R.

AU - Loeb, David M.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Angiogenesis is required for tumor growth. WT1, a protein that affects both mRNA transcription and splicing, has recently been shown to regulate expression of vascular endothelial growth factor (VEGF), one of the major mediators of angiogenesis. In the present study, we tested the hypothesis that WT1 is a key regulator of tumor angiogenesis in Ewing sarcoma. We expressed exogenous WT1 in the WT1-null Ewing sarcoma cell line, SK-ES-1, and we suppressed WT1 expression using shRNA in the WT1-positive Ewing sarcoma cell line, MHH-ES. Suppression of WT1 in MHH-ES cells impairs angiogenesis, while expression of WT1 in SK-ES-1 cells causes increased angiogenesis. Different WT1 isoforms result in vessels with distinct morphologies, and this correlates with preferential upregulation of particular VEGF isoforms. WT1-expressing tumors show increased expression of pro-angiogenic molecules such as VEGF, MMP9, Ang-1, and Tie-2, supporting the hypothesis that WT1 is a global regulator of angiogenesis. We also demonstrate that WT1 regulates the expression of a panel of pro-angiogenic molecules in Ewing sarcoma cell lines. Finally, we found that WT1 expression is correlated with VEGF expression, MMP9 expression, and microvessel density in samples of primary Ewing sarcoma. Thus, our results demonstrate that WT1 expression directly regulates tumor angiogenesis by controlling the expression of a panel of pro-angiogenic genes.

AB - Angiogenesis is required for tumor growth. WT1, a protein that affects both mRNA transcription and splicing, has recently been shown to regulate expression of vascular endothelial growth factor (VEGF), one of the major mediators of angiogenesis. In the present study, we tested the hypothesis that WT1 is a key regulator of tumor angiogenesis in Ewing sarcoma. We expressed exogenous WT1 in the WT1-null Ewing sarcoma cell line, SK-ES-1, and we suppressed WT1 expression using shRNA in the WT1-positive Ewing sarcoma cell line, MHH-ES. Suppression of WT1 in MHH-ES cells impairs angiogenesis, while expression of WT1 in SK-ES-1 cells causes increased angiogenesis. Different WT1 isoforms result in vessels with distinct morphologies, and this correlates with preferential upregulation of particular VEGF isoforms. WT1-expressing tumors show increased expression of pro-angiogenic molecules such as VEGF, MMP9, Ang-1, and Tie-2, supporting the hypothesis that WT1 is a global regulator of angiogenesis. We also demonstrate that WT1 regulates the expression of a panel of pro-angiogenic molecules in Ewing sarcoma cell lines. Finally, we found that WT1 expression is correlated with VEGF expression, MMP9 expression, and microvessel density in samples of primary Ewing sarcoma. Thus, our results demonstrate that WT1 expression directly regulates tumor angiogenesis by controlling the expression of a panel of pro-angiogenic genes.

KW - Alternative splicing

KW - Tissue microarray

KW - Transcriptional regulation

KW - Tumor angiogenesis

KW - Vascularity

UR - http://www.scopus.com/inward/record.url?scp=84901227839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901227839&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.1610

DO - 10.18632/oncotarget.1610

M3 - Article

C2 - 24810959

AN - SCOPUS:84901227839

VL - 5

SP - 2436

EP - 2449

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 9

ER -